Overview
Portfolio
More
Artis Ventures
San Francisco, United States
Artis Ventures invests in frontier technologies that converge technology with biology, targeting data‑driven life‑science companies. Their focus spans AI, biotech, digital health, healthtech, and medical devices to creat...
Portfolio
58+
Employees
30+
Founded
2001
AUM
≈ $1.0B
Investment focus
Stages
Series A → Series C+
Industries
Artificial IntelligenceBiotechnologyDigital HealthHealthcare Technology
Geographic scope
Global
Fund details
Funds
AI & Robotics Fund
AI First Fund
Blockchain & Fintech Fund
Deep Tech Fund
Healthtech Fund
Seed Fund
U.S. Strategic Tech Fund
Women’s Fund
The Foundation Fund
Sources
Artis Ventures
Artis Ventures invests in frontier technologies that converge technology with biology, targeting data‑driven life‑science companies. Their focus spans AI, biotech, digital health, healthtech, and medical devices to create scalable, personalized, and proactive health solutions.
Portfolio
58+
Employees
30+
Founded
2001
AUM
≈ $1.0B
Funds
AI & Robotics Fund
AI First Fund
Blockchain & Fintech Fund
Deep Tech Fund
Healthtech Fund
Seed Fund
U.S. Strategic Tech Fund
Women’s Fund
The Foundation Fund
Stages
Series A → Series C+
Industries
Artificial IntelligenceBiotechnologyDigital HealthHealthcare TechnologyMedical Devices
Geographic scope
Global
Sources
Showing 24 of 36 matched portfolio companies
Able utilizes artificial intelligence to streamline the commercial loan processing workflow, significantly reducing the time required for loan approvals. By automating data analysis and document verification, the platform enhances operational efficiency and minimizes the risk of human error in financial assessments.
Activ Surgical develops the ActivSight™ Intelligent Light, which utilizes augmented reality and machine learning to provide real-time visual insights into critical physiological structures during surgery. This technology addresses the high incidence of preventable surgical errors by enhancing surgeons' visibility beyond the naked eye, ultimately improving patient outcomes and surgical efficiency.
Funding: $101.9M
Rough estimate of the amount of funding raised
Funding: $101.9M
Rough estimate of the amount of funding raised
Affect Therapeutics offers a smartphone app that integrates contingency management with virtual therapy to support individuals recovering from drug and alcohol addiction. The platform provides financial incentives for healthy behaviors, along with personalized care and resources to facilitate lasting lifestyle changes.
Funding: $26.1M
Rough estimate of the amount of funding raised
Funding: $26.1M
Rough estimate of the amount of funding raised
Cerebral is a mental health telemedicine platform that connects users with licensed prescribers and therapists for online therapy and medication management. It addresses the lack of accessible mental health care by offering personalized treatment plans, progress tracking, and flexible session scheduling, all within a digital environment.
Funding: $461.4M
Rough estimate of the amount of funding raised
Funding: $461.4M
Rough estimate of the amount of funding raised
Climax produces dairy‑free cheeses using its patented CASEED™ plant protein, which replicates the melt, stretch, and flavor of dairy casein while delivering 80‑100% of the protein found in traditional cheese. The allergen‑free, high‑protein cheeses are made from seeds of regenerative crops, offering a lower‑carbon, lower‑water alternative suitable for food manufacturers, restaurants, and retailers seeking sustainable, high‑performance cheese products.
Funding: $35.5M
Rough estimate of the amount of funding raised
Funding: $35.5M
Rough estimate of the amount of funding raised
Cohesity provides hyper-converged secondary storage solutions that enable organizations to efficiently manage backups, files, and analytics at scale. Their technology ensures rapid data recovery and robust cyber protection, significantly reducing recovery time and costs associated with data loss.
Conceivable Life Sciences operates the world's first fully automated IVF lab, utilizing AI-powered automation to perform over 200 steps in embryo creation. This technology addresses the limited access to IVF by scaling production, improving success rates, and reducing costs, enabling more individuals to benefit from fertility treatments.
Funding: $38.0M
Rough estimate of the amount of funding raised
Funding: $38.0M
Rough estimate of the amount of funding raised
Creator Cash offers creators immediate access to their online earnings through cash advances and a suite of financial tools, including earnings analytics and invoicing features. This platform addresses the delay in receiving payments from platforms like YouTube, enabling creators to manage their income and expenses efficiently in one application.
Funding: $4.0M
Rough estimate of the amount of funding raised
Funding: $4.0M
Rough estimate of the amount of funding raised
CURE Finance provides specialized online banking and financial management software tailored for medical and dental practices. The platform automatically categorizes transactions, offers real-time liquidity analysis, and generates key performance indicators to improve practice profitability. Users gain financial transparency and AI-driven optimization tips to better control cash flow and make informed fiscal decisions.
Delfina provides a digital maternal health platform that connects pregnant individuals, their families, and care teams through a mobile app and virtual doula support. The app delivers trimester‑specific education, lets users track symptoms and vital signs, and securely shares data with obstetricians, health plans, or employers, while automated alerts prompt timely care. Providers and payors gain dashboards to monitor outcomes and coordinate interventions at scale.
Funding: $17.0M
Rough estimate of the amount of funding raised
Funding: $17.0M
Rough estimate of the amount of funding raised
Eko provides an end-to-end "Investments-as-a-Service" solution that allows banks and credit unions to integrate digital investment capabilities directly into their existing platforms without requiring additional development or staffing. This enables financial institutions to offer investment options starting from $10, increasing customer engagement and creating a new revenue stream through a revenue-sharing model.
Funding: $400.0K
Rough estimate of the amount of funding raised
Funding: $400.0K
Rough estimate of the amount of funding raised
This startup offers a clinical genome interpretation platform that uses AI algorithms to analyze genomic data from various sources. The platform delivers actionable genomic insights to medical professionals, enabling faster and more accurate diagnostic reports.
Fig provided visual applications, shortcuts, and autocomplete features for terminal users, enhancing command line efficiency. With the sunset of Fig, users are encouraged to transition to Amazon Q, which offers a faster and more reliable command line experience.
Provides a dietary and nutrition app that uses barcode scanning and an extensive ingredient database to identify food products matching users' dietary restrictions, such as allergies, intolerances, or lifestyle choices. The app simplifies meal planning and grocery shopping by offering personalized food recommendations from over 50 stores, eliminating the need for manual ingredient checks.
Heal is a nonprofit ecommerce platform that utilizes experience-based peer support to help individuals with mental illness reconnect with their passions through creative expression. By empowering emerging artists to showcase their work, Heal reinvests 100% of its profits into community-building initiatives that foster meaningful connections.
Aruba is a financial operating system designed for the MENA region that facilitates fast and convenient payment transfers and micro-services. The platform addresses inefficiencies in cross-border transactions, enabling businesses to streamline their financial operations and improve cash flow management.
Founded 2022
1000+
Approximate amount of employees
Funding: $25.0M
Rough estimate of the amount of funding raised
Funding: $25.0M
Rough estimate of the amount of funding raised
Mytos is developing a fully automated platform for the manufacture of any human cell type, utilizing advanced robotics and software to streamline cell culture processes. This technology addresses the challenges of contamination and human error in cell production, enabling consistent, high-quality output at a scale that allows one technician to achieve the productivity of ten scientists working manually.
Funding: $64.0M
Rough estimate of the amount of funding raised
Funding: $64.0M
Rough estimate of the amount of funding raised
Network B offers a white-label and API-based platform that enables businesses to create customizable rewards programs, enhancing customer engagement through a variety of offers such as cashback and vouchers. By integrating these solutions, companies can increase revenue streams and improve customer retention without compromising data security, as the platform adheres to ISO 27001 standards.
Founded 2020
Opyn provides a platform for trading options on Ethereum and ERC20 tokens, enabling users to earn premiums and express market views through decentralized finance. This service enhances liquidity and risk management for digital asset investors by offering accessible derivatives trading in the cryptocurrency market.
Funding: $6.7M
Rough estimate of the amount of funding raised
Funding: $6.7M
Rough estimate of the amount of funding raised
Ozlo Sleep develops specialized audio technology in the form of Sleepbuds, designed to enhance sleep quality by masking disruptive noises and promoting relaxation. These earbuds address the challenge of sleep disturbances without medication, providing users with a non-invasive solution to improve their sleep rituals.
Funding: $30.0M
Rough estimate of the amount of funding raised
Funding: $30.0M
Rough estimate of the amount of funding raised
This company provides software platforms like AIP, Foundry, and Gotham that integrate complex data for decision-making across government and commercial sectors. Their solutions enable organizations to automate operations, enhance intelligence analysis, and build custom applications using an Ontology-driven architecture. The platforms support real-time operations from factory floors to defense applications, driving efficiency and operational agility.
Funding: $10.1M
Rough estimate of the amount of funding raised
Funding: $10.1M
Rough estimate of the amount of funding raised
Power provides a cloud-native issuance platform that enables businesses to launch and scale customizable, white-labeled credit card programs within weeks. This technology addresses the need for flexible and efficient credit card solutions that enhance customer engagement and offer tailored rewards.
Funding: $316.1M
Rough estimate of the amount of funding raised
Funding: $316.1M
Rough estimate of the amount of funding raised
RAD AI utilizes machine learning algorithms to analyze real-time conversations from social media platforms, generating actionable audience insights within 24 hours. This technology enables brands to effectively target specific demographics with tailored messaging, enhancing engagement and campaign performance.
Funding: $12.3M
Rough estimate of the amount of funding raised
Funding: $12.3M
Rough estimate of the amount of funding raised
Range Biotechnologies provides an end-to-end solution focused on translational proteomics research. The company develops advanced platforms to analyze protein expression and function relevant to human health applications. This work aims to establish new standards for high-throughput proteomics data generation and interpretation.
Funding: $5.2M
Rough estimate of the amount of funding raised
Funding: $5.2M
Rough estimate of the amount of funding raised
Showing 12 of 22 unmatched portfolio companies
Freenome
No website provided
We don't have a full profile for this company yet.
StemCentrx
No website provided
We don't have a full profile for this company yet.
Replay
No website provided
We don't have a full profile for this company yet.
Siren Biotechnology
No website provided
We don't have a full profile for this company yet.
Unnatural Products
No website provided
We don't have a full profile for this company yet.
Type6 Therapeutics
No website provided
We don't have a full profile for this company yet.
Inceptive Nucleics
No website provided
We don't have a full profile for this company yet.
Aether Biomachines
No website provided
We don't have a full profile for this company yet.
TAE Life Sciences
No website provided
We don't have a full profile for this company yet.
Glyphic
No website provided
We don't have a full profile for this company yet.
Locus Biosciences
No website provided
We don't have a full profile for this company yet.
idbydna
No website provided
We don't have a full profile for this company yet.